T1000	Speculation 208 222	indicates that
E1000	Speculation:T1000 Scope:T1001
T1001	Span 208 377	indicates that the immune system and the hypothalamic-pituitary-adrenal system are linked by several mechanisms, for example intracellular glucocorticoid receptors (hGR)
T1002	Negation 75 78	not
E1001	Negation:T1002 Scope:T1003
T1003	Span 75 162	not in peripheral blood mononuclear cells from patients with inflammatory bowel disease
T1004	Speculation 694 696	or
E1002	Speculation:T1004 Scope:T1005
T1005	Span 615 756	patients were either treated with 5-60 mg of prednisolone for more than 1 week or were without glucocorticoid treatment for more than 4 weeks
T1006	Negation 702 709	without
E1003	Negation:T1006 Scope:T1007
T1007	Span 702 756	without glucocorticoid treatment for more than 4 weeks
T1008	Negation 1558 1565	absence
E1004	Negation:T1008 Scope:T1009
T1009	Span 1558 1593	absence of glucocorticoid treatment
T1010	Negation 1397 1400	not
E1005	Negation:T1010 Scope:T1011
T1011	Span 1397 1452	not differ significantly from those in control subjects
T1012	Negation 2128 2135	without
E1006	Negation:T1012 Scope:T1013
T1013	Span 2128 2204	without steroids were significantly different from those in control subjects
T1014	Negation 1721 1724	not
E1007	Negation:T1014 Scope:T1015
T1015	Span 1721 1827	not different from those in patients with ulcerative colitis (UC) (56.1 +/- 51.6 dpm mg-1 cytosol protein)
T1016	Speculation 2434 2442	probably
E1008	Speculation:T1016 Scope:T1017
T1017	Span 2434 2526	probably leading to a decreased protection against NF-kappaB action in the intestinal mucosa
T1018	Negation 2234 2236	no
E1009	Negation:T1018 Scope:T1019
T1019	Span 2234 2328	no difference in systemic hGR levels between not steroid-treated patients and control subjects
